These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 2533-69-9, its application will become more common.
Some common heterocyclic compound, 2533-69-9, name is Methyl 2,2,2-trichloroacetimidate, molecular formula is C3H4Cl3NO, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. Recommanded Product: Methyl 2,2,2-trichloroacetimidate
Examples 24 – 273-(3,5-dibromo-4-{[2-isopropylcarbamoyl-lH-benzimidazol-5-yl]oxy}phenyl)-2- fluoropropanoic acid3-(3,5-dibromo-4-{[2-ethylcarbamoyl-lH-benzimidazol-5-yl]oxy}phenyl)-2-fluoropropanoic acid3-(3,5-dibromo-4-{[2-diisopropylcarbamoyl-lH-benzimidazoI-5-yl]oxy}phenyl)-2- fluoropropanoic acid 5-[2,6-Dibromo-4-(2-fluoro-2-isopropylcarbanioyl-ethyI)-phenoxy]-lH-benzoimidazoIe-2- carboxylic acid ^^Methyl 3-[4-(4-amino-3-nitrophenoxy)-3,5-dibromo-phenyl]-2-fluoro-propanoate (intermediate 10) (22 mg, 0.045 mmol) and platinum oxide (2.3 mg, 0.010 mmol) were suspended in ethyl acetate (2 mL), and hydrogenated under pressure (5 psi) for 15 h. The reaction mixture was filtered through a celite pad and concentrated, purified by flash chromatography (methanol/dichloromethane 0:10 to 5:5) to give 19 mg (92 % yield) of methyl 3-[4-(4,3-diamino-phenoxy)-3,5-dibromo-phenyl]-2- fluoro-propanoate.Methyl 3-[4-(4,3-diamino-phenoxy)-3,5-dibromo-phenyl]-2-fluoro-propanoate was dissolved in acetic acid (0.1 mL) and cooled to 0 0C, methyl trichloroacetimidate (Cl3CC(NH)OMe) (6 muL, 0.045 mmol) was added. The reaction was stirred for 1 h at room temperature. Water was added and the product was extracted with dichloromethane using a phase separator to give methyl 3-(3,5-dibromo- 4-{[2-trichloromethyl-lH-benzimidazol-5-yl]oxy}phenyl)-2-fluoropropanoate which was used in the next step without further purification.The crude methyl 3-(3,5-dibromo-4-{[2-trichloromethyl-lH-benzimidazol-5-yl]oxy}phenyl)-2- fluoropropanoate was dissolved in 1 mL of a stock solution (100 muL isopropylamine, 162muL triethylamine, 24 mL ethanol) and stirred at room temperature over night. Potassium hydroxide (2 mL, 2 M) was added and the stirring continued for 1 h. Hydrochloric acid (1 M, 10 mL) was added and the mixture was extracted into ethyl acetate (3 x 30 mL). The combined organic phases were dried, filtered and concentrated. The obtained residue was purified by semi-preparative-HPLC (Zorbax CombiHT (SB-C8 50×21.2 mm, 5mu). Mobile Phase: Solvent A. Water with 0.5 % formic acid; Solvent B: acetonitrile. Gradient: 2 min 80 % of A then over 8 min to 5% of A) to give 1 mg (5 % yield over 3 steps) of 3-(3,5-dibromo-4-{[2-isopropylcarbamoyl-lH-benzimidazol-5- yl]oxy}phenyl)-2-fluoropropanoic acid and also unexpected 1 mg of 3-(3,5-dibromo-4-{[2- ethylcarbarnoyl-l H-benzimidazol-5-yl]oxy}phenyl)-2-fluoropropanoic acid, 0.8 mg of 3-(3,5- dibromo-4-{[2-diisopropylcarbamoyl-lH-benzimidazol-5-yl]oxy}phenyl)-2-fluoropropanoic acid and 0.7 mg of 5-[2,6-Dibromo-4-(2-fluoro-2-isopropylcarbamoyl-ethyl)-phenoxy]-l H- benzoimidazole-2-carboxylic acid.
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 2533-69-9, its application will become more common.
Reference:
Patent; KARO BIO AB; WO2007/128492; (2007); A1;,
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics